Determining cost-saving risk thresholds for statin use
A threshold for statin prescription in Germany set at a 10.2% 10-year CV risk could significantly increase the number of patients benefiting from statin therapy, reducing CV events and generating substantial cost savings. These findings suggest that adjustments to prescription guidelines could improve cardiovascular outcomes and economic efficiency within the German healthcare system.
Authors
- Afschin Gandjour
Institutions
- Frankfurt School of Finance & Management (DE)
Publication Details
- Journal
- PLoS ONE
- Published
- 2025-03-13
- DOI
- https://doi.org/10.1371/journal.pone.0318454
- Citations
- 1
- Primary Topic
- Health Systems, Economic Evaluations, Quality of Life
- Type
- article
- Field-Weighted Citation Impact
- 3.13